A Komen fundraising race from the fall. It hasn’t been a great week for Susan G. Komen for the Cure, the breast-cancer advocacy group known for its pink-ribbon fundraising efforts. Today the group reversed a decision — made public only Tuesday... 

Prostate-Cancer Drug Studies: The results from two trials of experimental drugs for advanced prostate cancer add to recent progress against the disease, the WSJ reports . Medivation’s MDV3100 extended survival by nearly five months in a 1,199-patient... 

The latest national health spending figures out Monday show slowed growth in medical expenditures in 2010 — and plenty of debate fodder for both policy wonks and political partisans. For a start, there’s little consensus among analysts over... 

Every year, there are reported cases of individuals who are diagnosed of having cancer. And, although there were already studies which focused its attention on the major risk factors that can be contributory to the initiation of the over growth of cells... 

Focus on Formula: Wal-Mart and Supervalu have removed certain containers of Mead Johnson Nutrition’s Enfamil infant formula from their store shelves following the death of a Missouri infant from a rare bacterial infection, the WSJ reports . The... 

A doc fix is looking like an increasingly unlikely holiday present for the nation’s physicians — and the patients they treat. Last year at this time a one-year patch for scheduled cuts to Medicare reimbursement was all squared away with a... 

Central to the drug-shortage issue is a chicken-and-egg question that often leaves legislators scratching their heads at congressional hearings. Chicken: Are the shortages of crucial drugs caused by factory flaws and shutdowns? Or egg: Are shortages... 

The health-care overhaul law includes a provision requiring insurers to spend a certain proportion of premium dollars on patient care and quality-improvement programs. It all sounds straightforward enough — large-group plans must spend at least... 

It seems like just yesterday that Congress passed a one-year fix for Medicare reimbursement cuts. Unfortunately, time has flown, and we find ourselves back on the “doc fix” watch — though this year, there’s a 24.7% cut looming.... 

One of the most closely-watched aspects of the federal health-overhaul law is a provision that requires insurers to spend a set proportion of premium dollars on patients’ care and quality-improvement efforts  — 85% for large groups, or 80% for...